Atlantic Union Bankshares Corp Sells 1,292 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atlantic Union Bankshares Corp decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 18,901 shares of the healthcare conglomerate’s stock after selling 1,292 shares during the quarter. UnitedHealth Group makes up about 0.9% of Atlantic Union Bankshares Corp’s portfolio, making the stock its 23rd largest position. Atlantic Union Bankshares Corp’s holdings in UnitedHealth Group were worth $9,951,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp lifted its position in shares of UnitedHealth Group by 1.7% in the 2nd quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate’s stock worth $22,260,241,000 after acquiring an additional 764,872 shares during the period. Wellington Management Group LLP lifted its position in shares of UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the period. Morgan Stanley raised its holdings in shares of UnitedHealth Group by 13.8% in the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after buying an additional 1,893,192 shares in the last quarter. Moneta Group Investment Advisors LLC increased its holdings in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares in the last quarter. Finally, Alliancebernstein L.P. increased its stake in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after buying an additional 399,739 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Piper Sandler reduced their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Stephens restated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Barclays started coverage on UnitedHealth Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $1.60 during trading on Friday, hitting $494.70. The company had a trading volume of 3,820,008 shares, compared to its average volume of 4,274,309. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The firm has a market capitalization of $456.08 billion, a P/E ratio of 20.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The stock’s 50-day moving average price is $502.66 and its 200 day moving average price is $518.44. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the previous year, the company posted $5.34 earnings per share. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.